Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
Stanford University, Palo Alto, California National Institutes of Health, Bethesda, Maryland Dana Farber Cancer Institute, Boston, Massachusetts Washington University, St Louis, Missouri Memorial Sloan Kettering Kids, New York, New York Duke University School of Medicine, Durham, North Carolina Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio Children's Hospital of Philedephia, Philadelphia, Pennsylvania Seattle Children's Hospital, Seattle, Washington University of Wisconsin Cancer Center, Madison, Wisconsin